Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China · Delayed Price · Currency is CNY 15.34
+0.12 (0.79%)
Oct 24, 2025, 2:45 PM CST
SHE:000739 Revenue
Apeloa Pharmaceutical Co.,Ltd had revenue of 2.32B CNY in the quarter ending September 30, 2025, a decrease of -18.94%. This brings the company's revenue in the last twelve months to 10.50B, down -14.42% year-over-year. In the year 2024, Apeloa Pharmaceutical Co.,Ltd had annual revenue of 12.02B with 4.77% growth.
Revenue (ttm)
10.50B
Revenue Growth
-14.42%
P/S Ratio
1.68
Revenue / Employee
1.49M
Employees
7,060
Market Cap
17.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.02B | 547.70M | 4.77% |
| Dec 31, 2023 | 11.47B | 929.26M | 8.81% |
| Jan 1, 2023 | 10.54B | 1.60B | 17.92% |
| Jan 1, 2022 | 8.94B | 1.06B | 13.49% |
| Dec 31, 2020 | 7.88B | 668.96M | 9.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |